Overview
- 4 inspections across 4 sites are on record.
- 8 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-03-28.
At a glance
Inspections
4
Sites
4
Observations
8
Career since
Apr 2019
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Boston Scientific Corporation | 28 Mar 2025 | Human Drugs | View 483 → |
| Ohm Laboratories Inc. | 16 May 2023 | Human Drugs | |
| Cisen Pharmaceuticals Co Ltd | 29 Nov 2019 | Human Drugs | |
| Mylan Laboratories Limited | 26 Apr 2019 | Human Drugs |
Sites inspected
Boston Scientific CorporationDorado, United States1 insp.
Ohm Laboratories Inc.New Brunswick, United States1 insp.
Cisen Pharmaceuticals Co LtdJining, China1 insp.
Mylan Laboratories LimitedAurangabad, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Santos E Camara1 shared
Victoria Spivak1 shared
Janet A Rajan1 shared
Truong X Nguyen1 shared
Jose M Cayuela1 shared
Full investigator report
Get the verbatim findings behind Satheesh K Podaralla's 8 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site